Cancer DiscovJClub
Correcting Mitochondrial Complex I Defect in Tumor-Associated Natural Killer Cells Potentiates Immunotherapy for Glioblastoma.
Cancer Discovery · · Journal Article
Zhou, Fei + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Restoring mitochondrial complex I activity via NDUFA9 enhances NK cell antitumor function in glioblastoma by reversing metabolic and epigenetic impairments.
- Why it matters: Glioblastoma remains resistant to many immunotherapies, partly due to impaired NK cell mitochondrial function, highlighting the need for strategies that improve NK cell efficacy in this cancer.
- What they did: The study used multiomics profiling to identify NDUFA9 as a key complex I subunit affecting NK cell metabolism, and employed Ndufa9 knockout and overexpression approaches, along with resveratrol treatment, to assess impacts on NK cell function.
- The result: Activating NDUFA9 restored complex I activity, improved NK cell antitumor responses, and suggests targeting mitochondrial complex I as a promising approach to enhance NK cell-based immunotherapy for GBM.
The findingWhy it mattersWhat they didThe result
- 1 cites